Business Wire

QUECTEL-WIRELESS

10.1.2024 18:01:36 CET | Business Wire | Press release

Share
Quectel announces industry-first certification of satellite communication module on Skylo network

CES – Quectel Wireless Solutions, a global IoT solutions provider, is pleased to announce the successful certification of Quectel's NTN-enabled module, the CC660D-LS, for use on the network by Skylo, the leading non-terrestrial network (NTN) service provider. The module is the first to be certified by Skylo for use on its network and enables seamless and reliable IoT-NTN connectivity for any standard device that incorporates the module and has a view of the sky.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240110653580/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Quectel announces industry-first certification of satellite communication module on Skylo network (Photo: Business Wire)

Quectel has developed the CC660D-LS module specifically to provide dependable and efficient, two-way, satellite communication capabilities. With the module's certification on the Skylo network, businesses and organizations can harness the power of Skylo's ubiquitous satellite connectivity to enable IoT applications in remote and challenging environments, ensuring that data is transmitted securely and reliably.

The CC660D-LS module provides a range of flexible connectivity options, encompassing L-band, S-band, and Band 23 connections. Notably, this module is equipped to support 3GPP Release 17 IoT non-terrestrial network (IoT-NTN) connections, reflecting its advanced capabilities. Prioritizing reliable connectivity, the CC660D-LS module excels in facilitating two-way communication. Furthermore, the module extends its support to both IP and Non-IP service networks. This dual capability ensures not only enhanced connectivity but also heightened service availability. The CC660D-LS module stands as a comprehensive solution for robust and versatile connectivity needs.

"We are delighted that Skylo has certified our NTN Satellite Communication Module for its network," said Norbert Muhrer, President and CSO, Quectel Wireless Solutions. "This certification reflects our commitment to delivering high-quality satellite communication solutions to our customers worldwide. By collaborating with Skylo, we enable businesses to unlock new opportunities and achieve their IoT goals, regardless of where they are located."

The Skylo certification process involved rigorous testing and evaluation to ensure that the CC660D-LS module meets stringent quality and performance standards, including 3GPP Release-17 standards and Skylo's Standards Plus qualifications. Skylo's network is designed to provide global coverage, ensuring that IoT devices equipped with Quectel's module can stay connected in areas with limited terrestrial infrastructure.

"We are excited to welcome Quectel's CC660D-LS module to our ecosystem of certified devices," said Dr Andrew Nuttall, CTO and Co-Founder of Skylo. "This certification is a testament to our commitment to providing the most reliable and expansive satellite based IoT connectivity. By partnering with industry leaders like Quectel, we empower device manufacturers of all types to expand their IoT applications, add additional review streams, and deliver a superior customer experience that requires no change in user behavior."

Quectel's CC660D-LS module is suitable for a wide range of applications, including asset tracking, fleet management, agriculture, maritime, and more. The module's compact design and low-power consumption make it an ideal choice for battery-powered IoT devices that require long-term, uninterrupted connectivity.

Quectel’s IoT modules are developed with security at the core. From product architecture to firmware/software development, Quectel incorporates leading industry practices and standards, mitigating potential vulnerabilities with third party independent test houses and have incorporated security practices like generating SBOMs and VEX files as well as performing firmware binary analysis into the entire software development lifecycle.

IoT developers now can streamline their development process by combining Quectel modules with Quectel's antennas and pre-certification services, effectively reducing both costs and time-to-market for their IoT devices. For the CC660D-LS satellite module, Quectel offers the YECN028AA and YFCA011AA antennas, providing developers with versatile options to enhance connectivity and expedite the deployment of their innovative solutions.

About Quectel

Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services. Our growing global team of 5,900 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules as well as antennas and services.

With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.

For more information, please visit: www.quectel.com, LinkedIn, Facebook, and X.

About Skylo

Skylo Technologies is an NTN service provider based in Mountain View, CA, offering a service that allows cellular modems and devices to connect directly over existing satellites. Devices connected over satellite are managed and served by Skylo’s commercial NTN vRAN, featuring a 3GPP standards-based cloud-native base station and core. Skylo works with existing satellite operators, terrestrial mobile network operators, and device makers to provide subscribers an anywhere, anytime connectivity solution that seamlessly roams between terrestrial and satellite networks. Skylo’s focus is on enabling connected services for people outdoors and connected workflows for machines at work across critical industries such as agriculture, maritime, logistics, mining, and others, in addition to mass-market consumer devices. For more information, visit www.skylo.tech, contact info@skylo.tech, or follow us on LinkedIn and Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240110653580/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ARIS Announced as Exclusive Process Intelligence Launch Partner for AWS European Sovereign Cloud8.6.2026 09:00:00 CEST | Press release

Partnership Will Enable Enterprises to Accelerate AI Adoption While Ensuring Digital Sovereignty ARIS, the process context foundation for enterprise AI deployment, today announced its collaboration with Amazon Web Services (AWS) to support organizations navigating increasingly complex digital sovereignty requirements while accelerating AI-driven transformation. Many European enterprises face growing pressure to ensure sensitive operational and business data remains under European governance and regulatory control. Through the AWS European Sovereign Cloud (ESC), they will be able to combine advanced cloud and AI capabilities with enhanced operational separation, EU-based governance, and strict data residency controls. ARIS will support customers looking to operationalize AI safely and at scale within these boundaries by providing the process intelligence, governance, and operational context required for trusted enterprise AI deployment. “AI is moving rapidly from experimentation to oper

Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy8.6.2026 08:00:00 CEST | Press release

Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workflow into a single environment. PlanOne™ is FDA 510(k) cleared. "PlanOne™ began with listening. Over the years, our work on control systems in radiation oncology has put us in direct, ongoing contact with medical physicists and clinical teams at some of the leading facilities in the world," said Mark Pleško, CEO of Cosylab. "Our partners have been clear on what matters most for particle therapy: physics accuracy they can defend, clinical confidence at the point of plan approval, and a platform built to grow with AI and adaptive workflows. We designed PlanOne™ around those three priorities, and we'll keep developing it together with the clinical community that helped shape it." Physics-accurate, radiobiologically informed planning PlanOne™ is built on a GPU-accelerated Monte Carlo dose engin

BitGo MENA Launches Regulated Electronic Trading, Delivering Full Suite Trading Services to the Region8.6.2026 06:00:00 CEST | Press release

BitGo MENA FZE (“BitGo MENA”), a subsidiary of BitGo Holdings, Inc. (NYSE: BTGO) (“BitGo”), the digital asset infrastructure company, today announced the launch of electronic trading in the Middle East and North African (MENA). With this launch, clients can now access a comprehensive trading solution combining BitGo MENA’s established over-the-counter (OTC) trading offering with institutional-grade electronic execution, all operating under BitGo MENA’s Broker-Dealer license from Dubai’s Virtual Assets Regulatory Authority (VARA). The launch further expands BitGo MENA’s regulated product suite under VARA’s oversight, marking another step in the region’s continued buildout of institutional digital asset infrastructure amid growing demand for integrated execution and custody solutions. “The Middle East and North Africa has quickly become one of the most exciting regions in the world for digital assets, with regulators, institutions, and innovators moving with real purpose,” said Mike Bels

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release

- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye